TEST BANK For Clayton’s Basic Pharmacology for Nurses 19th Edition Michelle Willihnganz, All Chapters 1 - 48, Complete A+ Guide ISBN:9780323812580 Newest Version

Test Bank For Clayton’s Basic Pharmacology for Nurses 19th EditionB y
L L L L L L L L L i
h L L



Michelle J. Willihnganz, Samuel L. Gurevitz, Bruce Clayton Complete
L L L L L L L L L

,Chapter 01: Drug Definitions, Standards, and Information Sources Willihnganz
L L L L L L L L L

: Clayton’s Basic Pharmacology for Nurses, 19th Edition
L L hi L L L L




MULTIPLELCHOICE

1. WhichLnameLidentifiesLaLdrug listedLbyLtheLUSLFoodLan
hi


LdDrugLAdministrationL(FDA)?
hi


a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS:L C
TheLofficialLnameLisLtheLnameLunderLwhichLaLdrugLisLlistedLb
yLtheLFDA.LTheLbrandLname,LorLtrademark,LisLtheLnameLgivLe
nLtoLaLdrugLbyLitsLmanufacturer.LTheLnonproprietary,LorLgenLe
ric,LnameLisLprovidedLbyLtheLUnitedLStatesLAdoptedLNamesL
Council.

DIF: CognitiveLLevel:LKnowledge REF:L p.L 9
OBJ:L1NAT:LNCLEXLClientLNeedsLCategory:LSafe,LEffectiveLCarLeEnviron hi


mentLTOP:LLLLNursingLProcessLStep:LAssessment
CON:
PatientL Education

2. WhichLsourceLcontainsLinformationLspecificLtoLnutritionalLsupplements?
a. USPLDictionaryLofL USANL &InternationalL DrugLNames
b. NaturalLMedicinesLComprehensiveLDatabase
c. UnitedLStatesLPharmacopoeia/NationalLFormularyL(USPNF)
d. DrugLInteractionLFacts
ANS:L C
UnitedLStatesLPharmacopoeia/NationalLFormularyLcontainsLinformationLspecificLtoLnutritionalLs hi


upplements.LUSPLDictionaryLofLUSANL &LInternationalLDrugLNamesLisLaLcompilationLofLdrugLn hi


ames,LpronunciationLguide,LandLpossibleLfutureLFDALapprovedLdrugs;LitLdoesLnotLincludeLnutLri
tionalLsupplements.L NaturalLMedicinesLComprehensiveLDatabaseLcontains
evidence-
basedLinformationLonLherbalLmedicinesLandLherbalLcombinationLproducts;LitLdoesLnotincludeLinf
hi


LormationLspecificLtoLnutritionalLsupplements.LDrugLInteractionLFactsLcontainsLcomprehensiv

eLinformation onLdrugL interactionLfacts;LitL doesLnotL includeLnutritionalLsupplements.
hi




DIF:LLL CognitiveLLevel:LKnowledge REF:LLL p.L4
OBJ:L3NAT:LL NCLEXLClientL NeedsL Category:LPhysiologicalLInte
hi


grity
TOP: Nursing ProcessLStep:LAssessment CON:LLLNutritionL|LPatientL Education
hi




3. Which drug referenceLcontainsLdrugLmonographsLthatLdescribeLallLdrugsLinLaLtherapeuticLclass?
hi hi


a. DrugLFactsLandLComparisons

,TestLBankL ForL Clayton’sL BasicLPharmacologyLforL NursesL 19thL Editi 3
o
b. DrugLInteractionLFacts
c. Handbook onLInjectableLDrugs hi


d. Martindale—TheLCompleteLDrugLReference

ANS:L A
DrugLFactsLandLComparisonsLcontainsLdrugLmonographsLthatLdescribeLallLdrugsLinLatL hi


herapeuticLclass.LMonographsLareLformattedLasLtablesLtoLallowLcomparisonLofsimilarprL
oducts,LbrandLnames,Lmanufacturers,LcostLindices,LandLavailableLdosageLformsLOnlineL
versionLisLavailable.

DIF: CognitiveLLevel:LKnowledge REF:LLLp.L 4 TableL1.2 hi


OBJ: 3 NAT:LL NCLEX Client Needs Category:LPhysiologicalLIntegrity
hi hi hi


TOP: Nursing ProcessLStep:LAssessment CON:LLLSafetyL|PatientL EducationL|ClinicalLJudgment
hi




4. WhichLdrug referenceL containsL monographsLaboutL virtuallyLeverysingle-
hi


Lentitydrug availableinLtheLUnitedLStatesLandLdescribesLtherapeuticLusesLofLdrugs,LincludingLa
hi hi


LpprovedLandLunapprovedLuses?
a. Martindale:LTheLCompleteLDrug Reference hi


b. AHFSLDrugLInformation
c. DrugL Reference
d. DrugLFactsLandLComparisons
ANS:L B
AHFSLDrugLInformationLcontainsLmonographsLaboutLvirtuallyLeveryLsingle-
entityLdrugLavailableLinLtheLUnitedLStatesLandLdescribesLtherapeuticLusesLofLdrugs,L includingLapL
provedLandunapprovedLuses.
hi




DIF: CognitiveLLevel:LKnowledge REF:LLLp.L 4 TableL1.2 hi


OBJ: 3 NAT:LL NCLEX Client NeedsLCategory:LPhysiologicalLIntegrity
hi hi


TOP: NursingLProcessLStep:LPlanning CON:L SafetyL|PatientL EducationL|ClinicalLJudgment

5. WhichLonlineLdrugLreferenceLmakesLavailableLtoLhealthcareLprovidersLand theLpublicLaLsta
hi


Lndard,Lcomprehensive,Lup-to-dateLlookLupLandLdownloadableLresourceLaboutLmedicines?
a. AmericanLDrugLIndex
b. AmericanL HospitalL Formulary
c. DailyMed
d. DrugLReference
ANS:L C
DailyMedLmakesLavailableLto healthcareLprovidersLandLtheLpublicLaLstandard,Lcomprehensive,L
hi hi


up-to-
dateLlookLupLandLdownloadableLresourceLaboutLmedicines.LTheLAmericanLDrugLIndexLisnotLapLpr hi


opriateLforLpatientLuse.LTheLAmericanLHospitalLFormularyLisLnotLappropriateLforLpatientL us
e. TheLdrugLreferenceL isL notL appropriateLforLpatientL use.

DIF: CognitiveLLevel:LKnowledge REF: p.L3L |Lp.L4
OBJ:L3NAT:LL NCLEXLClientL NeedsL Category:LPhysiologicalLInte
hi


grity
TOP:LLNursing ProcessLStep:LImplementation
hi


CON:L SafetyL|PatientLEducationL|LClinicalLJudgment

6. WhichLlegislationLauthorizesLtheLFDALtoLdetermineLtheLsafetyofLaLdrugLbeforeLitsLmarketing?
a. FederalLFood,LDrug,LandLCosmeticLActL(1938)
b. DurhamLHumphreyLAmendmentL (1952)

, TestLBankL ForL Clayton’sL BasicLPharmacologyLforL NursesL 19thL Editi 4
o
c. ControlledLSubstancesLAct (1970) hi


d. KefauverLHarrisLDrug AmendmentL(1962)
hi




ANS:L A
TheLFederalLFood,LDrug,LandLCosmeticLActLofL1938LauthorizedLtheLFDALtoLdetermineLtheLsafL
etyLofLallLdrugsLbeforeLmarketing.LLaterLamendmentsLandLactsLhelpedLtightenLFDALcontrolLanL
dLensureLdrugLsafety.LTheLDurhamLHumphreyLAmendmentLdefinesLtheLkindsLofLdrugsLthatLcanL
notLbeLusedLsafelyLwithoutLmedicalLsupervisionLandLrestrictsLtheirLsaleLtoLprescriptionLbyLaLlicL
ensedLpractitioner.LTheLControlledLSubstancesLActLaddressesLonlyLcontrolledLsubstancesLandthL hi


eirLcategorization.LTheLKefauverLHarrisLDrugLAmendmentLensuresLdrugLefficacyLandLgreaterdrL
ugLsafety.LDrugLmanufacturersLareLrequiredLtoLproveLtoLtheLFDALtheLeffectivenessLofLtheirLpro
LductsLbeforeL marketingLthem.




DIF: CognitiveLLevel:LKnowledge
REF:Lp.L5LTableLl.3LOBJ: 5
NAT:LNCLEXLClientLNeedsLCategory:LPhysiologicalLIntegri
tLyTOP:L NursingLProcessL Step:LAssessment
CON:L SafetyL|PatientL EducationL|LEvidenceL|LHealthLCareLLaw

7. WhichLclassificationLdoesLmeperidineL(Demerol)LfallLunder?
a. I
b. II
c. III
d. IV
ANS:L B
MeperidineL(Demerol)LisLa ScheduleLIILdrug;LitLhasLaLhighLpotentialLforLabuseLandLmayLleadLtoL
hi hi


severeLpsychologicalLandLphysicalLdependence.LScheduleLI drugsLhaveLhighLpotentialLforLabuseLa
hi hi


ndLnoLrecognizedLmedicalLuse.LScheduleLIIILdrugsLhaveLsomeLpotentialLforLabuse.LUseLmayLlLe
adLtoLlowLtoLmoderateLphysicalLdependenceLorLhighLpsychologicalLdependence.LScheduleLIVLd
rugsLhaveLlowLpotentialLforLabuse.LUseLmayLleadLtoLlimitedLphysicalLorLpsychologicalLdepenLd
ence.

DIF: CognitiveLLevel:LKnowledge REF: p.L10
OBJ:L2NAT:LLNCLEXLClientLNeedsLCategory:LSafe,LEffectiveLCar
hi


LeLEnvironment

TOP: NursingLProcessLStep:LAssessment CON:L PatientL EducationL|AddictionL|Pain

8. WhichLactionLwouldLtheLFDALtakeLtoLexpediteLdrugLdevelopmentL andLapprovalLforLanLoutbreakL hi


ofLsmallpox?
a. ListLsmallpoxLasLaLhealthLorphan disease. hi


b. OmitLthe preclinicalLresearchLphase.
hi


c. ExtendLtheLclinical researchLphase.
hi


d. FastLtrackLthe investigationalLdrug.
hi




ANS:L D
OnceLtheLInvestigationalLNewLDrugLApplicationLhasLbeenLapproved,LtheLdrugLcanLreceiveLhigL
hestLpriorityLwithinLtheLagency,LwhichLisLcalledLfastLtracking.LALsmallpoxLoutbreakLwouldLbec
LomeLaLpriorityLconcernLinLtheLworld.LOrphanLdiseasesLareLnotLresearched LinLaLpriorityLmanner

.LPreclinicalLresearchLisLnotLomitted.LExtendingLanyLphaseLofLtheLresearchLwouldLmeanaLlonger
hi


LtimeLtoLdevelopLaLvaccine.LTheLFDALmustLensureLthatLallLphasesLofLtheLpreclinicalLandclinicalLr
hi


eLsearchLphaseL haveL beenLcompletedLinLaLsafeLmanner.

DIF:L L CognitiveLLevel:LKnowledge REF:LLL p.L7 OBJ:L 5